Cost-benefit of stockpiling drugs for influenza pandemic

We analyzed strategies for the use of stockpiled antiviral drugs in the context of a future influenza pandemic and estimated cost-benefit ratios. Current stockpiling of oseltamivir appears to be cost-saving to the economy under several treatment strategies, including therapeutic treatment of patient...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Emerging infectious diseases 2005-08, Vol.11 (8), p.1280-1282
Hauptverfasser:	Balicer, Ran D, Huerta, Michael, Davidovitch, Nadav, Grotto, Itamar
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetamides - economics Acetamides - therapeutic use Adolescent Adult Aged Antiviral agents Antiviral Agents - economics Antiviral Agents - therapeutic use Child Child, Preschool Cost-Benefit Analysis disease outbreaks Disease Outbreaks - economics Dispatch Drug therapy Economic aspects Epidemics Humans Infant Influenza Influenza, Human - drug therapy Influenza, Human - economics Influenza, Human - epidemiology Israel Israel - epidemiology Keywords: antiviral agents Middle Aged Models, Biological Models, Economic Oseltamivir Prevention Prevention and Control United States World Health Organization
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	We analyzed strategies for the use of stockpiled antiviral drugs in the context of a future influenza pandemic and estimated cost-benefit ratios. Current stockpiling of oseltamivir appears to be cost-saving to the economy under several treatment strategies, including therapeutic treatment of patients and postexposure prophylactic treatment of patients' close contacts.
ISSN:	1080-6040 1080-6059
DOI:	10.3201/eid1108.041156